Abstract:An increasing number of artemisinin (ARS) and its derivatives have been reported for their potential therapeutic value of human cancer. However, their therapeutic potencies are limited owing to their poor pharmacokinetic profiles. Our previous studies showed that a lead compound ARS4 originated from incorporating the pharmacophore of the approved chemotherapeutic agent melphalan into the basic skeleton of artemisinin with a succinic linker exhibited an excellent toxicity to human ovarian cancer cells and low cytotoxicity to normal cells. The mechanism studies demonstrated that it inhibited the growth and proliferation of ovarian cancer cells and resulted in S-phase arrest, apoptosis and inhibition of migration. Meanwhile, it exhibited excellent antitumor activities in animal models. Herein, further structure optimization for this lead compound ARS4 was performed and nineteen novel derivatives were designed and synthesized. Among them, compounds 10-12, 15, 16, 18 and 19 demonstrated powerful cytotoxic effects against human liver cancer and ovarian cancer cell lines, with their IC50s below 0.86 μM against Hep3B and A2780 cell lines, which are superior to that of ARS4. Four compounds (11, 15, 16 and 18) were selected to further evaluate their antitumor activities in in vitro and in vivo ovarian and liver cancer models, the results indicated that compound 18 exhibited the best therapeutic effect, not only effectively inhibited the growth of 7404 xenograft and Huh7 xenograft, but also presented a good dose-dependent inhibition toward the growth of A2780 xenograft. Overall, based on these positive results, these novel chemical structures may provide a new inspiration for the discovery of novel antitumor agents originated from artemisinin scaffolds.

Research Progress on Pharmacological Activities of Artemisinin and Its Derivatives

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment

Arctigenin: Pharmacology, Total Synthesis, and Progress in Structure Modification

Artemisinin and Its Derivatives as Potential Anticancer Agents

Antiviral effects of artemisinin and its derivatives

Advances in the research on the targets of anti-malaria actions of artemisinin

New clinical application prospects of artemisinin and its derivatives: a scoping review

Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.

The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease

Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

Research progress on pharmacological activities and development utilization of Artemisia argyi Levi.et Vant.

Advanced metabolic engineering strategies for increasing artemisinin yield in Artemisia annua L

Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug

Traditional application and modern pharmacological research of Artemisia annua L.

Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties—Pharmacokinetics and Pharmacodynamics: A Review

Recent Advances in the Research of Pharmacological Activities of Panax Notoginseng Saponins

Progress on the Study of Anti-tumor Mechanisms of Dihydroartemisinin

Artemisinins: Promising drug candidates for the treatment of autoimmune diseases

Interactions Between Fungal Endophytes And Their Host Artemisa Annua: Growth, Antifungi Activity And Artemisinin Biosynthesis

Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers